Longeveron Mesenchymal Stem Cells ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
211Hypoplastic left heart syndrome1

211. Hypoplastic left heart syndrome


Clinical trials : 21 Drugs : 29 - (DrugBank : 9) / Drug target genes : 5 - Drug target pathways : 14
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03525418
(ClinicalTrials.gov)
February 21, 201819/2/2018Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)HLHSBiological: Longeveron Mesenchymal Stem CellsLongeveron Inc.NULLCompletedN/A1 YearAll10Phase 1/Phase 2United States